1. Home
  2. Research
  3. Research Groups
  4. Neuroproteins-stroke

Neuroproteins-stroke

Search for publications

Only original articles, editorials, guidelines.

  • Cariaga-Martínez A, Gutierrez KJ, Regidor I, Del Álamo M, Saiz-Ruiz J, Alelú-Paz R.

    A Refined Approach to Isolate Interneurons for High-Validity Epigenetic Studies in Human Brain Tissue

    Methods And Protocols . 8(3): .

    [doi:10.3390/mps8030061]

  • Chavarría-Cubel I, Molina YL, Babiy B, Lerma M, Martínez-Botas J, de la Peña G, Vallejo MT, Villanueva-Blanco T, Gómez-Coronado D, Alcazar A, Lasunción MA, Pastor Ó, Busto R.

    The synthetic TRPML1 agonist ML-SA1 mitigates intracellular lipid accumulation induced by antipsychotics in vitro by stimulating release of extracellular microvesicles

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS . 1870(4): 159611-159611.

    [doi:10.1016/j.bbalip.2025.159611]

  • Martínez García B, Chico García JL, Pérez Gil D, Garay Albízuri P, Llanes Ferrer A, García Alcántara G, Cabañas Engenios G, Matute Lozano MC, de Felipe Mimbrera A, Vera Lechuga R, Cruz Culebras A, Carrión Sánchez I, Fernández-Golfín C, Masjuan J, García Madrona S.

    Grading Right-to-Left Shunt With Transforaminal Doppler: A Valid Approach in Patients With Cryptogenic Stroke

    JOURNAL OF NEUROIMAGING . 35(1): . Number of citations: 1

    [doi:10.1111/jon.70023]

  • Cabañes-Martínez L, Fedirchyk-Tymchuk O, López Viñas L, Abreu-Calderón F, Carrasco Moro R, Del Álamo M, Regidor I.

    Usefulness of Intraoperative Neurophysiological Monitoring in Intradural Spinal Tumor Surgeries.

    Journal Of Clinical Medicine . 13(24): .

    [doi:10.3390/jcm13247588]

  • Sainz-Amo R, Rodero-Romero A, Monreal E, Chico-García JL, Rodríguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Veiga-González JL, de la Maza SS, Masjuan J, Costa-Frossard L, Villar LM.

    Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(23): .

    [doi:10.3390/ijms252313153]

  • Monreal E, Fernández-Velasco JI, Álvarez-Lafuente R, Sainz de la Maza S, García-Sánchez MI, Llufriu S, Casanova B, Comabella M, Martínez-Yélamos S, Galimberti D, Ramió-Torrentà L, Martínez-Ginés ML, Aladro Y, Ayuso L, Martínez-Rodríguez JE, Brieva L, Villarrubia N, Eichau S, Zamora J, Rodero-Romero A, Espiño M, Blanco Y, Saiz A, Montalbán X, Tintoré M, Domínguez-Mozo MI, Cuello JP, Romero-Pinel L, Ghezzi L, Pilo de la Fuente B, Pérez-Miralles F, Quiroga-Varela A, Rubio L, Rodríguez-Jorge F, Chico-García JL, Sainz-Amo R, Masjuan J, Costa-Frossard L, Villar LM.

    Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.

    Brain . 147(12): 4084-4093. Number of citations: 2

    [doi:10.1093/brain/awae260]

  • Rodríguez-Pardo J, García-Castro J, Gómez-Escalonilla C, García-Torres A, García-Pastor A, Vivancos-Mora J, Fernández-Ferro J, Cruz-Culebras A, Carneado-Ruiz J, Granja-López J, Estebas-Armas C, Lorenzo-Diéguez M, González-Sarmiento R, García-Yu R, Alvarez-Muelas A, Navas-Vinagre I, Oses-Lara M, Iglesias-Mohedano A, Santos L, de la Rosa C, Alonso de Leciñana M, Díez-Tejedor E, Ruiz-Ares G, Rigual R, de Celis E, Hervás-Testal C, Casado-Fernández L, González-Martín L, Navía P, Fernandez-Prieto A, Frutos R, Fuentes B.

    Burden of incidental cerebral aneurysms on lifestyle and quality of life: a survey of patients in expectant management (the SPICE Study).

    JOURNAL OF NEUROINTERVENTIONAL SURGERY . : .

    [doi:10.1136/jnis-2024-022459]

  • Rodríguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Gracia-Gil J, Fernández E, Meca-Lallana V, Díaz-Pérez C, Sainz de la Maza S, Pacheco EM, Quiroga A, Ramió-Torrentà L, Martínez-Yélamos S, Bau L, Monreal E, López-Real A, Rodero-Romero A, Borrega L, Díaz S, Eguía P, Espiño M, Chico-García JL, Barrero FJ, Martínez-Ginés ML, García-Domínguez JM, De la Fuente S, Moreno I, Sainz-Amo R, Mañé-Martínez MA, Caminero A, Castellanos F, Gómez López A, Labiano-Fontcuberta A, Ayuso L, Abreu R, Hernández MÁ, Meca-Lallana J, Martín-Aguilar L, Muriel García A, Masjuan J, Costa-Frossard L, Villar LM.

    Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

    Frontiers in immunology . 15: 1480676-1480676.

    [doi:10.3389/fimmu.2024.1480676]

  • Chico-Garcia, Juan Luis, Amo, Raquel Sainz, Monreal, Enric, de la Maza, Susana Sainz, Jorge, Fernando Rodriguez, Masjuan, Jaime, Costa-Frossard, Lucienne, Villar, Luisa Maria.

    Progression independent of relapse activity can be predicted by passively acquired tapping speed through a smartphone for 1 month: A prospective study

    MULTIPLE SCLEROSIS JOURNAL . 30(10): 1239-1349.

    [doi:10.1177/13524585241272960]

  • Sainz de la Maza S, Rodero-Romero A, Monreal E, Chico-García JL, Villarrubia N, Rodríguez-Jorge F, Fernández-Velasco JI, Sainz-Amo R, Costa-Frossard L, Masjuan J, Villar LM.

    COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis.

    Frontiers in immunology . 15: 1439393-1439393.

    [doi:10.3389/fimmu.2024.1439393]

  • Sainz-Amo R, Rodero Romero A, Monreal E, Chico García JL, Fernández Velasco JI, Villarrubia N, Veiga González JL, Sainz de la Maza S, Rodríguez Jorge F, Masjuan J, Costa-Frossard L, Villar LM.

    Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis.

    Frontiers in immunology . 15: 1454474-1454474.

    [doi:10.3389/fimmu.2024.1454474]

  • Fernández-Serra R, Lekouaghet A, Peracho L, Yonesi M, Alcázar A, Chioua M, Marco-Contelles J, Pérez-Rigueiro J, Rojo FJ, Panetsos F, Guinea GV, González-Nieto D.

    Permselectivity of Silk Fibroin Hydrogels for Advanced Drug Delivery Neurotherapies.

    Biomacromolecules . 25(8): 5233-5250. Number of citations: 1

    [doi:10.1021/acs.biomac.4c00629]

  • Rodero-Romero A, Monreal E, Sainz-Amo R, García Domínguez JM, Villarrubia N, Veiga-González JL, Fernández-Velasco JI, Goicochea-Briceño H, Rodríguez-Jorge F, Sainz de la Maza S, Chico-García JL, Muriel A, Masjuan J, Costa-Frossard L, Villar LM.

    Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(14): .

    [doi:10.3390/ijms25147808]

  • Chen CH, Shoamanesh A, Colorado P, Saad F, Lemmens R, De Marchis GM, Caso V, Xu L, Heenan L, Masjuan J, Christensen H, Connolly SJ, Khatri P, Mundl H, Hart RG, Smith EE.

    Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE.

    Stroke . 55(6): 1477-1488.

    [doi:10.1161/STROKEAHA.123.045204]

  • Carretero VJ, Liccardi N, Tejedor MA, de Pascual R, Campano JH, Hernández-Guijo JM.

    Lead exerts a depression of neurotransmitter release through a blockade of voltage dependent calcium channels in chromaffin cells.

    Toxicology . 505: 153809-153809.

    [doi:10.1016/j.tox.2024.153809]

  • Chico-Garcia JL, Sainz-Amo R, Monreal E, Rodriguez-Jorge F, Sainz de la Maza S, Masjuan J, Villar LM, Costa-Frossard França L.

    Passive assessment of tapping speed through smartphone is useful for monitoring multiple sclerosis.

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 86: 105595-105595. Number of citations: 1

    [doi:10.1016/j.msard.2024.105595]

  • Aaron S, Ferreira JM, Coutinho JM, Canhão P, Conforto AB, Arauz A, Carvalho M, Masjuan J, Sharma VK, Putaala J, Uyttenboogaart M, Werring DJ, Bazan R, Mohindra S, Weber J, Coert BA, Kirubakaran P, Sanchez van Kammen M, Singh P, Aguiar de Sousa D, Ferro JM.

    Outcomes of Decompressive Surgery for Patients With Severe Cerebral Venous Thrombosis: DECOMPRESS2 Observational Study.

    Stroke . 55(5): 1218-1226.

    [doi:10.1161/STROKEAHA.123.045051]

  • Scutelnic A, van de Munckhof A, Miraclin AT, Aaron S, Hameed S, Wasay M, Grosu O, Krzywicka K, Sánchez van Kammen M, Lindgren E, Moreira T, Acampora R, Negro A, Karapanayiotides T, Yaghi S, Revert A, Cuadrado Godia E, Garcia-Madrona S, La Spina P, Grillo F, Giammello F, Nguyen TN, Abdalkader M, Buture A, Sofia Cotelli M, Raposo N, Tsivgoulis G, Candelaresi P, Ciacciarelli A, Mbroh J, Batenkova T, Scoppettuolo P, Zedde M, Pascarella R, Antonenko K, Kristoffersen ES, Kremer Hovinga JA, Jood K, Aguiar de Sousa D, Poli S, Tatlisumak T, Putaala J, Coutinho JM, Ferro JM, Arnold M, Heldner MR.

    Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19.

    European Stroke Journal . 9(3): 676-686.

    [doi:10.1177/23969873241241885]